269 related articles for article (PubMed ID: 22161940)
1. [Psychotherapeutic and pharmacological treatment of pediatric obsessive-compulsive disorder].
Vloet TD; Simons M; Herpertz-Dahlmann B
Z Kinder Jugendpsychiatr Psychother; 2012 Jan; 40(1):29-39; quiz 39-40. PubMed ID: 22161940
[TBL] [Abstract][Full Text] [Related]
2. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).
Del Casale A; Sorice S; Padovano A; Simmaco M; Ferracuti S; Lamis DA; Rapinesi C; Sani G; Girardi P; Kotzalidis GD; Pompili M
Curr Neuropharmacol; 2019; 17(8):710-736. PubMed ID: 30101713
[TBL] [Abstract][Full Text] [Related]
3. Assessment and management of treatment-refractory obsessive-compulsive disorder in children.
Bloch MH; Storch EA
J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):251-62. PubMed ID: 25791142
[TBL] [Abstract][Full Text] [Related]
4. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
Varigonda AL; Jakubovski E; Bloch MH
J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940
[TBL] [Abstract][Full Text] [Related]
5. Obsessive-compulsive disorder (OCD): Practical strategies for pharmacological and somatic treatment in adults.
Fineberg NA; Reghunandanan S; Simpson HB; Phillips KA; Richter MA; Matthews K; Stein DJ; Sareen J; Brown A; Sookman D;
Psychiatry Res; 2015 May; 227(1):114-25. PubMed ID: 25681005
[TBL] [Abstract][Full Text] [Related]
6. [A Review and Recommendations of Evidence-Based Treatments for Pediatric Obsessive-Compulsive Disorder].
Skarphedinsson G; Lauth B; Njardvik U; Ivarsson T
Laeknabladid; 2016 Apr; 102(4):179-85. PubMed ID: 27197125
[TBL] [Abstract][Full Text] [Related]
7. Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part I: pharmacological treatment.
de Oliveira MVS; de Barros PMF; de Mathis MA; Boavista R; Chacon P; Echevarria MAN; Ferrão YA; Vattimo EFQ; Lopes AC; Torres AR; Diniz JB; Fontenelle LF; Rosário MCD; Shavitt RG; Miguel EC; da Silva RMF; Costa DLDC
Braz J Psychiatry; 2023 May; 45(2):146-161. PubMed ID: 36749887
[TBL] [Abstract][Full Text] [Related]
8. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy.
Albert U; Marazziti D; Di Salvo G; Solia F; Rosso G; Maina G
Curr Med Chem; 2018; 25(41):5647-5661. PubMed ID: 29278206
[TBL] [Abstract][Full Text] [Related]
9. Differential efficacy of cognitive-behavioral therapy and pharmacological treatments for pediatric obsessive-compulsive disorder: a meta-analysis.
Sánchez-Meca J; Rosa-Alcázar AI; Iniesta-Sepúlveda M; Rosa-Alcázar A
J Anxiety Disord; 2014 Jan; 28(1):31-44. PubMed ID: 24334214
[TBL] [Abstract][Full Text] [Related]
10. What Is the Added Benefit of Combining Cognitive Behavioral Therapy and Selective Serotonin Reuptake Inhibitors in Youth with Obsessive Compulsive Disorder? A Bayesian Hierarchical Modeling Meta-Analysis.
Mendez EM; Dahlsgaard KK; Hjelmgren JM; Mills JA; Suresh V; Strawn JR
J Child Adolesc Psychopharmacol; 2023 Aug; 33(6):203-211. PubMed ID: 37347947
[No Abstract] [Full Text] [Related]
11. Augmenting SRIs for Obsessive-Compulsive Disorder: Patient Preference for Risperidone Does Not Limit Effectiveness of Exposure and Ritual Prevention.
Wheaton MG; Carpenter JK; Kalanthroff E; Foa EB; Simpson HB
Psychother Psychosom; 2016; 85(5):314-6. PubMed ID: 27513584
[TBL] [Abstract][Full Text] [Related]
12. Combining Drug and Psychological Treatments for Obsessive- Compulsive Disorder: What is the Evidence, When and for Whom.
Albert U; Di Salvo G; Solia F; Rosso G; Maina G
Curr Med Chem; 2018; 25(41):5632-5646. PubMed ID: 28707590
[TBL] [Abstract][Full Text] [Related]
13. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.
Simpson HB; Gorfinkle KS; Liebowitz MR
J Clin Psychiatry; 1999 Sep; 60(9):584-90. PubMed ID: 10520976
[TBL] [Abstract][Full Text] [Related]
14. A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.
Matsunaga H; Nagata T; Hayashida K; Ohya K; Kiriike N; Stein DJ
J Clin Psychiatry; 2009 Jun; 70(6):863-8. PubMed ID: 19422759
[TBL] [Abstract][Full Text] [Related]
15. [Evidence-based pharmacotherapy and other somatic treatment approaches for obsessive-compulsive disorder: state of the art].
Kordon A; Zurowski B; Wahl K; Hohagen F
Nervenarzt; 2011 Mar; 82(3):319-20, 322-4. PubMed ID: 21340636
[TBL] [Abstract][Full Text] [Related]
16. Change in obsessive-compulsive symptoms mediates subsequent change in depressive symptoms during exposure and response prevention.
Zandberg LJ; Zang Y; McLean CP; Yeh R; Simpson HB; Foa EB
Behav Res Ther; 2015 May; 68():76-81. PubMed ID: 25824533
[TBL] [Abstract][Full Text] [Related]
17. Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Tundo A; Salvati L; Busto G; Di Spigno D; Falcini R
J Clin Psychiatry; 2007 Oct; 68(10):1552-6. PubMed ID: 17960971
[TBL] [Abstract][Full Text] [Related]
18. Treating obsessive compulsive disorder.
Veale D
Practitioner; 2002 Mar; 246(1632):181, 184-6. PubMed ID: 11901781
[No Abstract] [Full Text] [Related]
19. Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review.
Abramowitz JS
J Consult Clin Psychol; 1997 Feb; 65(1):44-52. PubMed ID: 9103733
[TBL] [Abstract][Full Text] [Related]
20. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.
Farrell LJ; Waters AM; Boschen MJ; Hattingh L; McConnell H; Milliner EL; Collings N; Zimmer-Gembeck M; Shelton D; Ollendick TH; Testa C; Storch EA
Depress Anxiety; 2013 Aug; 30(8):723-31. PubMed ID: 23722990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
